Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design; Human Psychopharmacology: Clinical and Experimental; Vol. 37, iss. 3

מידע ביבליוגרפי
Parent link:Human Psychopharmacology: Clinical and Experimental
Vol. 37, iss. 3.— 2022.— [e2826, 10 p.]
מחבר תאגידי: Национальный исследовательский Томский политехнический университет Инженерная школа неразрушающего контроля и безопасности Отделение контроля и диагностики
מחברים אחרים: Geers L. M. Lisanne, Ochi T. Taichi, Vyalova N. M. Nataljya Mikhaylovna, Losenkov I. S., Paderina D. Z. Diana, Pozhidaev I. V. Ivan Vyacheslavovich, Simutkin G. G. German Gennadjevich, Bokhan N. A. Nikolay Aleksandrovich, Wilffert B. Bob, Touw D. J. Daniël, Loonen A. Anton, Ivanova S. A. Svetlana Aleksandrovna
סיכום:Title screen
Background: Many antidepressants are substrates of P-glycoprotein, an efflux transporter in the blood-brain-barrier encoded by the ABCB1 gene. Genetic variations might influence the transport rate of antidepressants and hence their pharmacological effects. This study investigates the influence of eight polymorphisms in the ABCB1 gene on antidepressant treatment response. Method: 152 patients were included from psychiatric departments of the Mental Health Research Institute in Tomsk. The difference in Hamilton-Depression-Rating-Scale (HAMD-17)-scores between baseline and week two, week two and four, and baseline and week four was used to estimate timing of improvement of depression. Associations between the ABCB1 gene-polymorphisms and reduction in HAMD-17 score were assessed using independent t-test and multiple linear regression. Results: Tricyclic antidepressants were associated with a higher reduction of HAMD-17 score when compared to SSRIs. The SNP rs2235040 A-allele had a significant positive influence on the ΔHAMD-17(0→2W) score but a significant negative influence on the ΔHAMD-17(2→4W) score. The rs4148739 G-allele had a significant negative influence on the ΔHAMD-17(0→2W) score but a significant positive influence on the ΔHAMD-17(2→4W) score. The SNP rs2235015 T-allele is significant negatively related to the ΔHAMD-17(2→4W) score. Conclusion: ABCB1 Genetic variations appear to affect speed but not magnitude of antidepressant drug response.
שפה:אנגלית
יצא לאור: 2022
נושאים:
גישה מקוונת:https://doi.org/10.1002/hup.2826
פורמט: MixedMaterials אלקטרוני Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=668225

MARC

LEADER 00000naa0a2200000 4500
001 668225
005 20250317161919.0
035 |a (RuTPU)RU\TPU\network\39449 
035 |a RU\TPU\network\33755 
090 |a 668225 
100 |a 20220701d2022 k||y0rusy50 ba 
101 0 |a eng 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design  |f L. M. Geers, T. Ochi, N. M. Vyalova [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
330 |a Background: Many antidepressants are substrates of P-glycoprotein, an efflux transporter in the blood-brain-barrier encoded by the ABCB1 gene. Genetic variations might influence the transport rate of antidepressants and hence their pharmacological effects. This study investigates the influence of eight polymorphisms in the ABCB1 gene on antidepressant treatment response. Method: 152 patients were included from psychiatric departments of the Mental Health Research Institute in Tomsk. The difference in Hamilton-Depression-Rating-Scale (HAMD-17)-scores between baseline and week two, week two and four, and baseline and week four was used to estimate timing of improvement of depression. Associations between the ABCB1 gene-polymorphisms and reduction in HAMD-17 score were assessed using independent t-test and multiple linear regression. Results: Tricyclic antidepressants were associated with a higher reduction of HAMD-17 score when compared to SSRIs. The SNP rs2235040 A-allele had a significant positive influence on the ΔHAMD-17(0→2W) score but a significant negative influence on the ΔHAMD-17(2→4W) score. The rs4148739 G-allele had a significant negative influence on the ΔHAMD-17(0→2W) score but a significant positive influence on the ΔHAMD-17(2→4W) score. The SNP rs2235015 T-allele is significant negatively related to the ΔHAMD-17(2→4W) score. Conclusion: ABCB1 Genetic variations appear to affect speed but not magnitude of antidepressant drug response. 
461 |t Human Psychopharmacology: Clinical and Experimental 
463 |t Vol. 37, iss. 3  |v [e2826, 10 p.]  |d 2022 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a ABCB1 gene 
610 1 |a antidepressants 
610 1 |a Hamilton Depression Rating Scale 
610 1 |a P-glycoprotein 
610 1 |a гены 
610 1 |a антидепрессанты 
701 1 |a Geers  |b L. M.  |g Lisanne 
701 1 |a Ochi  |b T.  |g Taichi 
701 1 |a Vyalova  |b N. M.  |g Nataljya Mikhaylovna 
701 1 |a Losenkov  |b I. S.  |c Innokenty Sergeevich 
701 1 |a Paderina  |b D. Z.  |g Diana 
701 1 |a Pozhidaev  |b I. V.  |g Ivan Vyacheslavovich 
701 1 |a Simutkin  |b G. G.  |g German Gennadjevich 
701 1 |a Bokhan  |b N. A.  |g Nikolay Aleksandrovich 
701 1 |a Wilffert  |b B.  |g Bob 
701 1 |a Touw  |b D. J.  |g Daniël 
701 1 |a Loonen  |b A.  |g Anton 
701 1 |a Ivanova  |b S. A.  |c specialist in the field of ecology and life safety  |c Professor of Tomsk Polytechnic University, doctor of medical sciences  |f 1964-  |g Svetlana Aleksandrovna  |3 (RuTPU)RU\TPU\pers\33859 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Инженерная школа неразрушающего контроля и безопасности  |b Отделение контроля и диагностики  |3 (RuTPU)RU\TPU\col\23584 
801 0 |a RU  |b 63413507  |c 20220701  |g RCR 
856 4 |u https://doi.org/10.1002/hup.2826 
942 |c CF